EClinicalMedicine
SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis
Cohort study of 3,569 peopleInterventions
The paper
Tri-Service General Hospital
EClinicalMedicine, 28 Jul 2026

